Cleared Traditional

K203547 - Nalu Neurostimulation System (FDA 510(k) Clearance)

Mar 2021
Decision
111d
Days
Class 2
Risk

K203547 is an FDA 510(k) clearance for the Nalu Neurostimulation System. This device is classified as a Stimulator, Spinal-cord, Implanted (pain Relief) (Class II - Special Controls, product code GZB).

Submitted by Boston Scientific Neuromodulation (Valencia, US). The FDA issued a Cleared decision on March 25, 2021, 111 days after receiving the submission on December 4, 2020.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5880.

Submission Details

510(k) Number K203547 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 04, 2020
Decision Date March 25, 2021
Days to Decision 111 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GZB — Stimulator, Spinal-cord, Implanted (pain Relief)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5880